Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03654547
Title Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TransThera Sciences (Nanjing), Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Cancer Hopital Chinese Academy of Medical Sciences Beijing Beijing 100000 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field